Coloplast A/S EPS
The Earnings per Share (EPS) of Coloplast A/S (COLO B.CO) as of Oct 10, 2026 is 16.16 DKK. In the previous year, Earnings per Share (EPS) was 22.42 DKK — a change of -27.93% (lower).
Get this data via API
Financial Data API
EPS
16.16DKK
YoY
-27.93%
Last updated:
The Coloplast A/S EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| est | 36.68DKK | +8.83% |
| est | 33.71DKK | +6.81% |
| est | 31.56DKK | +21.12% |
| est | 26.06DKK | +4.97% |
| est | 24.82DKK | +53.61% |
| 16.16DKK | -27.93% | |
| 22.42DKK | +2.44% | |
| 21.89DKK | -1.20% | |
| 22.16DKK | -2.08% | |
| 22.63DKK | +14.67% | |
| 19.73DKK | +8.66% | |
| 18.16DKK | +0.44% | |
| 18.08DKK | +1.27% | |
| 17.85DKK | +20.49% | |
| 14.82DKK | +251.38% | |
| 4.22DKK | -62.40% | |
| 11.22DKK | -11.11% | |
| 12.62DKK | +23.20% | |
| 10.24DKK | +20.04% | |
| 8.53DKK | +47.02% | |
| 5.80DKK | +41.70% | |
| 4.10DKK | +22.85% | |
| 3.33DKK | +103.03% | |
| 1.64DKK | -20.60% | |
| 2.07DKK | — |
Coloplast A/S Stock analysis
Frequently Asked Questions about Coloplast A/S stock
Earnings per Share (EPS) of Coloplast A/S is 16.16 DKK in 2025.
Earnings per Share (EPS) of Coloplast A/S changed from 22.42 DKK to 16.16 DKK, representing a -27.93% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Coloplast A/S since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Income Statement — Coloplast A/S
All Key Metrics — Coloplast A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth